Gene · 1859
Papers3,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Resolving structural variations missed by short-read sequencing uncovers their pathogenicity. | J Med Genet | 2025 | 40835298 | PubTator, text mining | PubMed |
| Targeted therapy for knee osteoarthritis: From basic to clinics. | Medicine (Baltimore) | 2025 | 40826764 | PubTator, text mining | PubMed |
| Early cerebrospinal fluid elevations of pTau-217 in severe traumatic brain injury subjects. | Front Neurol | 2025 | 40808925 | PubTator, text mining | PubMed |
| Unravelling genetic etiology of cerebral palsy: findings from a Slovenian pediatric cohort. | Front Neurol | 2025 | 40771987 | PubTator, text mining | PubMed |
| Identification of Novel Scaffolds Against GSK-3β for Targeting Alzheimer's Disease Through Molecular Modeling Techniques. | Cell Mol Neurobiol | 2025 | 40760108 | PubTator, text mining | PubMed |
| Integrative bioinformatics analysis and experimental validation identify CHEK1 as an unfavorable prognostic biomarker related to immunosuppressive phenotypes in soft tissue sarcomas. | NPJ Precis Oncol | 2025 | 40751074 | PubTator, text mining | PubMed |
| PI3K/Akt Signaling Pathway Regulates CD155 Expression Involved in Resistance to Cancer Immunotherapy. | Cancer Immunol Res | 2025 | 40742385 | PubTator, text mining | PubMed |
| Computer-aided discovery of triazolothiadiazoles as DYRK1A-targeted neuroprotective agents. | RSC Med Chem | 2025 | 40741053 | PubTator, text mining | PubMed |
| Tricyclic Isatin Derivatives as Anti-Inflammatory Compounds with High Kinase Binding Affinity. | Molecules | 2025 | 40733180 | PubTator, text mining | PubMed |
| Pharmacological CLK inhibition disrupts SR protein function and RNA splicing blocking cell growth and migration in TNBC. | Breast Cancer Res | 2025 | 40731028 | PubTator, text mining | PubMed |
| Synthesis, biological evaluation and clinical trials of Cereblon-based PROTACs. | Commun Chem | 2025 | 40730655 | PubTator, text mining | PubMed |
| Discovery of Dietary Plant Flavonols as Novel Potent Inhibitors Targeting DYRK1A Kinase. | Biomolecules | 2025 | 40723805 | PubTator, text mining | PubMed |
| Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Network Pharmacology Reveal the Mechanisms of Rhodiola crenulata in Improving Non-Alcoholic Fatty Liver Disease. | Curr Issues Mol Biol | 2025 | 40699724 | PubTator, text mining | PubMed |
| Advances in Drug Discovery for Cardiomyocyte Proliferation. | Curr Treat Options Cardiovasc Med | 2025 | 40693046 | PubTator, text mining | PubMed |
| Proinflammatory transcriptomic and kinomic alterations in astrocytes derived from patients with familial Alzheimer's disease. | Brain Behav Immun Health | 2025 | 40656638 | PubTator, text mining | PubMed |
| Interneuron migration defects during corticogenesis contribute to Dyrk1a haploinsufficiency syndrome pathogenesis. | Mol Psychiatry | 2025 | 40634533 | PubTator, text mining | PubMed |
| [125I]IPPI for Tau Imaging: Binding Studies in Postmortem Human Alzheimer's Disease Hippocampus-Subiculum and Evaluation of Drug Effects. | Synapse | 2025 | 40619690 | PubTator, text mining | PubMed |
| Myocardial phosphoproteomics unveils a key role of DYRK1A in aortic valve replacement-induced reverse remodelling. | Basic Res Cardiol | 2025 | 40618317 | PubTator, text mining | PubMed |
| [Mechanism of DYRK1A in Cytarabine Resistance in Acute Myeloid Leukemia]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 40613151 | PubTator, text mining | PubMed |
| Unlocking the Conformational Secrets of DYRK1A Kinase With Computational Microscope: Exploring Phosphorylation-Driven Structural Dynamics. | J Comput Chem | 2025 | 40583493 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1859/papers?page=7